Assessing the Importance of Lymphovascular Invasion Prediction in Invasive Lung Adenocarcinoma Patients Through Intratumoral and Peritumoral CT Radiomics Models - Report - MDSpire

Assessing the Importance of Lymphovascular Invasion Prediction in Invasive Lung Adenocarcinoma Patients Through Intratumoral and Peritumoral CT Radiomics Models

  • By

  • Miaomiao Lin

  • Chunli Zhao

  • Haipeng Huang

  • Xiang Zhao

  • Siyu Yang

  • Xixin He

  • Kai Li

  • November 12, 2025

  • 0 min

Share

Clinical Report: Assessing the Importance of Lymphovascular Invasion Prediction in Invasive Lung Adenocarcinoma Patients Through Intratumoral and Peritumoral CT Radiomics Models

Overview

This study explores the development of a non-invasive model using CT radiomics to predict lymphovascular invasion (LVI) in patients with invasive lung adenocarcinoma (LUAD). The findings suggest that integrating intratumoral and peritumoral features can enhance the accuracy of LVI prediction, which is crucial for patient prognosis and treatment planning.

Background

Lung cancer remains the leading cause of cancer-related deaths globally, with adenocarcinoma being the most common subtype. LVI is a significant prognostic factor associated with higher recurrence rates and poorer survival outcomes in lung cancer patients. Despite its importance, LVI is not yet formally included in the TNM staging system, highlighting the need for improved predictive methods.

Data Highlights

No numerical data available in the source material.

Key Findings

  • LVI is a critical factor for assessing prognosis in lung adenocarcinoma patients.
  • Current methods for detecting LVI rely heavily on invasive pathology, which has limitations.
  • CT radiomics can provide non-invasive biomarkers for predicting LVI status.
  • The study proposes a combined model using GPT-Radscore and clinical factors to enhance prediction accuracy.
  • Peritumoral features may offer additional insights into LVI and tumor behavior.

Clinical Implications

The ability to predict LVI non-invasively can significantly impact treatment decisions and risk stratification for lung adenocarcinoma patients. Incorporating radiomic models into clinical practice may lead to more personalized treatment plans and improved patient outcomes.

Conclusion

This study underscores the potential of CT radiomics in predicting lymphovascular invasion in lung adenocarcinoma, which could enhance clinical decision-making and patient management strategies.

Related Resources & Content

  1. Lymphovascular Invasion is a Predictor of Postoperative Recurrence or Death in Stage I Non-small-cell Lung Cancer (NSCLC) - PubMed, 2025
  2. CT-Based Radiogenomics Evaluation of Metastatic Lung Adenocarcinoma: A Study of Single and Multi-Site Analysis and Its Impact on Patient Outcomes, European Radiology, 2025
  3. Improved Immunotherapy Response Prediction in NSCLC With Deep-Learning Radiomic Biomarker, asco ai in oncology, 2026
  4. Quantifying Early-Stage Lung Adenocarcinoma Progression with a Radiomic Trajectory, npj Digital Medicine, 2025
  5. Adjuvant Osimertinib Improves Overall Survival in EGFR-Mutated NSCLC, NEJM, 2025
  6. asco ai in oncology — Improved Immunotherapy Response Prediction in NSCLC With Deep-Learning Radiomic Biomarker
  7. European Radiology — Development and external validation of FDG PET-CT-based models for predicting outcomes in anal squamous cell carcinoma prior to treatment
  8. The clinical value of predicting lymphovascular invasion in patients with invasive lung adenocarcinoma based on the intratumoral and peritumoral CT radiomics models
  9. Lymphovascular Invasion is a Predictor of Postoperative Recurrence or Death in Stage I Non-small-cell Lung Cancer (NSCLC) - PubMed
  10. Adjuvant Osimertinib Improves Overall Survival in EGFR-Mutated NSCLC

Original Source(s)

Related Content